by Bruce Sylvester: Topiramate, an FDA-approved anticonvulsant drug which had been shown to reduce drinking in patients committed to complete abstinence, appears to help problem drinkers whose want… read more.
by Bruce Sylvester – Mild electronic stimulation therapy during sleep to the upper airway reduces obstructive sleep apnea (OSA) researchers reported in the Jan. 9 issue of the New… read more.
by Bruce Sylvester – Fibromyalgia syndrome (FMS) patients with low vitamin D can reduce pain by taking supplements, and possibly lower the costs of other drug and non-drug… read more.
by Bruce Sylvester – Less than half of Americans with eye damage caused by diabetes are aware of the connection between diabetes and visual impairment, researchers reported online… read more.
by Bruce Sylvester – Researchers have developed a new method to predicting which patients with heart failure will do well with treatment and which patients will not.
by Bruce Sylvester – While early stem cell transplantation in patients with aggressive non-Hodgkin’s lymphoma does not improve overall survival in intermediate/high-risk patients, early transplantation appears to be… read more.
by Bruce Sylvester – While early stem cell transplantation in patients with aggressive non-Hodgkin’s lymphoma does not improve overall survival in intermediate/high-risk patients, early transplantation appears to be… read more.
by Bruce Sylvester – Women who have undergone bariatric surgery are more likely to give birth to premature babies and to babies who are small for gestational age,… read more.
by Bruce Sylvester – Prophylactic use of the breast cancer drug anastrozole for five years reduced by 53% the development of breast cancer in post-menopausal women at high… read more.
by Bruce Sylvester – Gabapentin, a treatment for epilepsy and neuropathic pain, appears to be safe and effective for treating alcohol dependence, researchers reported in JAMA Internal Medicine on… read more.
by Bruce Sylvester – Abatacept, an FDA-approved treatment of rheumatoid arthritis could become the first targeted therapy for focal segmental glomerulosclerosis glomerulosclerosis (FSGS), a condition that usually causes… read more.
by Bruce Sylvester – An investigative drug could offer the first safe and effective treatment for psychotic symptoms that affect about half of people with Parkinson’s disease, researchers… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
